Are mouse models of human mycobacterial diseases relevant? Genetics says: 'yes!'

Immunology

Volumn 134, Issue 2, 2011, Pages 109-115

  Apt, Alexander S ^a  

^a CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

Author keywords

Genetic homology; Humans; Immunity; Mice; Mycobacteria

Indexed keywords

ACCURACY; ALLELE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; IPR1 GENE; MYCOBACTERIOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SLC11A1 GENE; SP110 GENE; TUBERCULOSIS;

ANIMALS; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; IMMUNE SYSTEM DISEASES; INTERFERON REGULATORY FACTORS; MICE; MULTIFACTORIAL INHERITANCE; NUCLEAR PROTEINS; SEVERITY OF ILLNESS INDEX; TRANS-ACTIVATORS; TUBERCULOSIS;

EID: 80052500448     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03472.x     Document Type: Note

References (91)

1. Flynn JL. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 2006; 8:1179-88.
2. Tsai MC, Chakravarty S, Zhu G et al. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 2006; 8:218-32.
3. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 1997; 78:57-66.
4. McMurray DN, Collins FM, Dannenberg AM Jr, Smith DW. Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol 1996; 215:157-79.
5. Orme IM. Development of new vaccines and drugs for TB: limitations and potential strategic errors. Future Microbiol 2011; 6:161-77.
6. Apt A, Kramnik I. Man and mouse TB: contradictions and solutions. Tuberculosis (Edinb) 2009; 89:195-8.
7. Young D. Animal models of tuberculosis. Eur J Immunol 2009; 39:2011-4.
8. Berning AK, Eicher EM, Paul WE, Scher I. Mapping of the X-linked immune deficiency mutation (xid) of CBA/N mice. J Immunol 1980; 124:1875-7.
9. Rawlings DJ, Saffran DC, Tsukada S et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993; 261:358-61.
10. Thomas JD, Sideras P, Smith CI, Vorechovsky I, Chapman V, Paul WE. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993; 261:355-8.
11. de Weers M, Mensink RG, Kraakman ME, Schuurman RK, Hendriks RW. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. Hum Mol Genet 1994; 3:161-6.
12. Gershwin ME. DiGeorge syndrome: congenital thymic hypoplasia. Animal model: congenitally athymic (nude) mouse. Am J Pathol 1977; 89:809-12.
13. Koller B, Smithies O. Altering genes in animals by gene targeting. Annu Rev Immunol 1992; 10:705-30.
14. Mak TW, Penninger JM, Ohashi PS. Knockout mice: a paradigm shift in modern immunology. Nat Rev Immunol 2001; 1:11-9.
15. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27:393-422.
16. Flesch I, Kaufmann SHE. Mycobacterial growth inhibition by interferon-γ-activated bone marrow macrophages and differential susceptibility among strains of Mycobacteriun tuberculosis. J Immunol 1987; 138:4408-13.
17. Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993; 167:1481-97.
18. Rook GAW, Steele J, Ainsworth M, Champion BR. Activation of macrophages to inhibit proliferation of Mycobacteriun tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 1986; 59:333-8.
19. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
20. Casanova JL, Blanche S, Emile JF et al. Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics 1996; 98:774-8.
21. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fisher A. Immunological conditions of children with BCG disseminated infection. Lancet 1995; 346:581.
22. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20:581-620.
23. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000; 11:321-3.
24. Levin M, Newport MJ, D'Souza S et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345:79-83.
25. Fortin A, Abel L, Casanova JL, Gros P. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annu Rev Genomics Hum Genet 2007; 8:163-92.
26. Filipe-Santos O, Bustamante J, Chapgier A. Inborn errors of IL-12/23 and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18:347-61.
27. Hamosh A, Scott AF, Ambereger JS, Bocchini CA, McKusick VA. Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005; 33:D514-7.
28. Alcais A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med 2005; 202:1617-21.
29. Jouanguy E, Lamhamedi S, Altare F. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 1997; 100:2658-64.
30. Bustamante J, Arias AA, Vogt G et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 2011; 12:213-22.
31. Adams LB, Dinauer MC, Morgenstern DE, Krahenbuhl JL. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber Lung Dis 1997; 78:237-46.
32. phox-/- mice. Infect Immun 2000; 68:1231-4.
33. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006; 24:353-89.
34. Inohara C, McDonald C, Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005; 74:355-83.
35. Skamene E, Gros P, Forget A, Kongshavn PA, Charles C, Taylor BA. Genetic regulation of resistance to intracellular pathogens. Nature 1982; 297:506-9.
36. Vidal S, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73:469-85.
37. Forbes JR, Gros P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 2003; 102:1884-92.
38. Malo D, Vogan K, Hu J et al. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 1994; 23:51-61.
39. Awomoyi AA, Marchant A, Howson JMM, McAdam K, Blackwell JM, Newport MJ. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002; 186:1808-14.
40. Bellamy R, Ruwende C, Corrah T, McAdam K, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338:640-4.
41. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 2002; 186:1463-8.
42. Malik S, Abel L, Tooker H et al. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci U S A 2005; 102:12183-8.
43. Abel L, Sanchez FO, Oberti J et al. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998; 177:133-45.
44. Meisner SJ, Mucklow S, Warner G, Sow SO, Lienhardt C, Hill AV. Association of NRAMP1 polymorphism with leprosy type but not susceptibility to leprosy per se in West Africans. Am J Trop Med Hyg 2001; 65:733-5.
45. Greenwood CM, Fujiwara TM et al. Linkage of tuberculosis to chromosom 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000; 67:405-16.
46. Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan R. Tumor necrosis factor α (-238 and -308) and β gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis 2001; 81:335-41.
47. Rossouw M, Nel HJ, Cooke GS, van Henden PD, Hoal EG. Association between tuberculosis and a polymorphic NFκB binding site in the interferon γ gene. Lancet 2003; 361:1871-2.
48. Medina E, North RJ. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J Exp Med 1996; 183:1045-51.
49. Nikonenko BV, Apt AS, Mezhlumova MB, Avdienko VG, Yeremeev VV, Moroz AM. Influence of the mouse Bcg, Tbc-1 and xid genes on resistance and immune responses to tuberculosis infection and efficacy of bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol 1996; 104:37-43.
50. Nakamura RN. Effect of natural resistance gene on the immune response against Mycobacterium avium complex infection. Kekkaku 1992; 67:41-6.
51. Kondratieva EV, Evstifeev VV, Kondratieva TK, Petrovskaya SN, Pichugin AV, Rubakova EI, Averbakh MM Jr, Apt AS. I/St mice hypersusceptible to Mycobacterium tuberculosis are resistant to M. avium. Infect Immun 2007; 75:4762-8.
52. Horsburgh CR Jr. Mycobacterium avium complex in the acquired immunodeficiency syndrome (AIDS). N Engl J Med 1991; 324:1332-8.
53. Inderlied CB, Kemper CA, Bermudez LE. The Mycobacterium avium complex. Clin Microbiol Rev 1993; 6:266-310.
54. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne B. Incidence of Mycobactereium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992; 165:1082-5.
55. Ehlers S, Benini J, Held HD et al. Alpha-beta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J Exp Med 2001; 194:1847-59.
56. Kondratieva EV, Logunova N, Majorov KB, Averbakh MM, Apt AS. Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to Mycobacterium tuberculosis and M. avium. PLoS ONE 2010; 5:e10515.
57. Kramnik I, Demant P, Bloom B. Susceptibility to tuberculosis as a complex genetic trait: analysis using recombinant congenic strains of mice. Novartis Found Symp 1998; 217:120-31.
58. Kramnik I, Dietrich WF, Demant P, Bloom B. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2000; 97:8560-5.
59. Schurr E, Kramnik I. Genetic control of host susceptibility to tuberculosis. In: Kaufmann SHE, Britton WJ, eds. Handbook of Tuberculosis: Immunology and Cell Biology. Weinheim: WILEY-VCH Verlag, 2008:295-336.
60. Pan H, Yan B-S, Rojas M et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005; 434:767-72.
61. Boyartchuk V, Rojas M, Yan BS et al. The host resistance locus sst1 controls innate immunity to Listeria monocytogenes infection in immunodeficient mice. J Immunol 2004; 173:5112-20.
62. Kadereit S, Gewert DR, Galabru J, Hovanessian AG, Meurs EF. Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J Biol Chem 1993; 268:24432-41.
63. Szeszko JS, Healy B, Stevens H, Balabanova Y, Drobniewski F, Todd JA, Nejentsev S. Resequencing and association analysis of the SP110 gene in adult pulmonary tuberculosis. Hum Genet 2007; 121:155-60.
64. Cong J, Li G, Zhou D, Tao Y, Xing Y. Study on relation between SP110 gene polymorphism and tuberculosis genetic susceptibility of Chongqing Han People. Wei Sheng Yan Jiu 2010; 39:540-4.
65. Constantoulakis P, Filiou E, Rovina N et al. In vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection. BMC Infect Dis 2010; 18:243.
66. Ruiz-Larranäga O, Garrido JM, Iriondo M et al. SP110 as a novel susceptibility gene for Mycobacterium avium subspecies paratuberculosis infection in cattle. J Dairy Sci 2010; 93:5950-8.
67. Sanchez F, Radaeva TV, Nikonenko BV et al. Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. Infect Immun 2003; 71:126-31.
68. Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Infect Dis 1999; 180:150-5.
69. Turcotte K, Loredo-Osti JC, Fortin P, Schurr E, Morgan K, Gros P. Complex genetic control of susceptibility to Mycobacterium bovis (Bacille Calmette-Guérin) infection in wild-derived Mus spretus mice. Genes Immun 2006; 7:684-7.
70. Yan B-S, Kirby A, Shebzukhov YV, Daly MJ, Kramnik I. Genetic architecture of tuberculosis resistance in a mouse model of infection. Genes Immun 2006; 7:201-10.
71. Mitsos LM, Cardon LR, Fortin A, Ryan L, LaCourse R et al. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun 2000; 1:467-77.
72. Mitsos LM, Cardon LR, Ryan L, LaCourse R, North RJ, Gros P. Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc Natl Acad Sci U S A 2003; 100:6610-5.
73. Apt AS, Nickonenko BV, Avdeenko VG, Kramnik IB, Moroz AM, Skamene E. Distinct H-2 complex control of mortality and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin Exp Immunol 1993; 94:322-32.
74. Pichugin AV, Petrovskaya SN, Apt AS. H2 complex controls CD4/CD8 ratio, recurrent responsiveness to repeated stimulations, and resistance to activation-induced apoptosis during T cell response to mycobacterial antigens. J Leukoc Biol 2006; 79:739-46.
75. Delgado JC, Baena A, Thim S, Goldfeld AE. Aspartic acid homozygosity at codon 57 of HLA-DQβ is associated with susceptibility to pulmonary tuberculosis in Cambodia. J Immunol 2006; 176:1090-7.
76. Korotetskaya MV, Kapina MA, Averbakh MM, Evstifeev VV, Apt AS, Logunova NN. A locus involved in tuberculosis infection control in mice locates in the proximal part of the H2 complex. Mol Biol (Russian) 2011; 45:68-76. (Cover-to-cover English translation: Mol Biol 2011; 45:46-53).
77. Marquis JF, LaCourse R, Ryan L, North RJ, Gros P. Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8. J Immunol 2009; 182:3008-15.
78. Turcotte K, Gauthier S, Mitsos LM, Shustik C, Copeland NG et al. Genetic control of myeloproliferation in BXH-2 mice. Blood 2004; 103:2343-50.
79. Turcotte K, Gauthier S, Tuite A, Mullick A, Malo D, Gros P. A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med 2005; 201:881-90.
80. Tailor P, Tamura T, Morse HC III, Ozato K. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 2008; 111:1942-5.
81. Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 2003; 170:1131-5.
82. Hambelton S, Salem S, Bustamante J et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011; 364, 10.1056/NEJMoa1100066.
83. Smith I, Nathan C, Peavy H. Progress and new directions in genetics of tuberculosis. A NHLBI working group report. Am J Respir Crit Care Med 2005; 172:1491-6.
84. Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci U S A 1991; 88:5528-32.
85. Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991; 138:1379-87.
86. Ferguson PJ, Blanton SH, Saulsbury FT et al. Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am J Med Genet 2000; 90:390-7.
87. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39:537-45.
88. + T regulatory cells. Nat Immunol 2003; 4:337-42.
89. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
90. + regulatory T cells. Nat Immunol 2003; 4:330-6.
91. + regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010; 10:849-59.